Brief: Joint Corp. To Close Underperforming Clinics In 2026
06/08/2026 23:32
BRIEF-Joint Corp. To Close Underperforming Clinics In 2026 Aug 7 (Reuters) - Joint Corp JYNT.O:
JOINT OUTLOOK FY ADJUSTED EBITDA USD 12.5-13.5 MILLION
JOINT Q2 REVENUE USD 15.2 MILLION VERSUS. IBES ESTIMATE USD 14.6 MILLION
JOINT CORP: TOTAL CLINIC COUNT WAS 941 AT JUNE 30, 2026
JOINT CORP: TO CLOSE UNDERPERFORMING CLINICS IN 2026; CLINIC COUNT AT 2026 YEAR END EXPECTED LOWER THAN 2025 YEAR END
JOINT OUTLOOK FY ADJUSTED EBITDA USD 12.5-13.5 MILLION
JOINT Q2 REVENUE USD 15.2 MILLION VERSUS. IBES ESTIMATE USD 14.6 MILLION
JOINT CORP - 2026 NEW FRANCHISED CLINIC OPENINGS EXPECTED TO BE 22-26
JOINT CORP: TOTAL CLINIC COUNT WAS 941 AT JUNE 30, 2026
Further company coverage: JYNT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Joint
See all newsBrief: Joint Corp To Reacquire Texas Regional Development Rights And Terminate Related Agreements
Brief: Joint Corp. To Close Underperforming Clinics In 2026
Joint Corp reports results for the quarter ended June 30 - Earnings Summary
The Joint Corp Q2 revenue beats estimates, reiterates 2026 outlook
Brief: Joint Q2 EPS USD 0.05